Beijing Tong Ren Tang Chinese Medicine Company Limited (FRA:TQR)

Market Cap	715.26M -12.3%
Revenue (ttm)	165.60M -6.1%
Net Income	43.47M -20.6%
EPS	0.05 -20.6%
Shares Out	n/a
PE Ratio	16.46
Forward PE	14.57
Dividend	0.04 (4.70%)
Ex-Dividend Date	Jun 5, 2025

Volume	n/a
Average Volume	1
Open	0.8250
Previous Close	0.8250
Day's Range	0.8250 - 0.8250
52-Week Range	0.8250 - 1.0500
Beta	n/a
RSI	22.31
Earnings Date	Mar 20, 2026

About FRA:TQR

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. It operates through three segments: Hong Kong, Mainland China, and Overseas. The company offers Chinese medical consultation and treatment services. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand name. Be...

• Industry: Drug Stores and Proprietary Stores
• Founded: 1669
• Employees: 789
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TQR

Financial Performance

In 2025, FRA:TQR's revenue was 1.51 billion, a decrease of -6.10% compared to the previous year's 1.61 billion. Earnings were 397.22 million, a decrease of -20.60%.

Financial numbers in HKD